Antiviral Drugs for Cirrhosis and Hepatitis

Viruses are the intracellular parasites that depend on synthetic processes of host cells. They cannot be grown on ordinary medium. Special microscopes are needed to visualize their structure, which consists of Genome (genetic material consisting of DNA or RNA component but never both), Surrounding capsid –proteinaceous in structure, Envelope –protein bilayer. Hepatitis B virus (HBV) is an important cause of end-stage liver disease and hepatocellular carcinoma (HCC). The decision to treat is based on the activity of liver disease and HBV replication status, and the likelihood of a long-term benefit. Approved therapies include standard and pegylated interferon-alfa and nucleoside analogues: lamivudine, adefovir and entecavir. Even with successful therapy, patients remain at risk for reactivation of viral replication and require lifelong monitoring.

HBV in HBsAg-positive patients treated with allogeneic hematopoietic cell transplantation. Highly active antiretroviral therapy is initiated for decreasing mortality relating to HIV. Influenza can be type A, B or C depending upon type. Influenza A and B are more common.

  • Anti-retroviral agents
  • Antiviral Regimens
  • Anti-herpes virus agents
  • Anti influenza agents

Related Conference of Antiviral Drugs for Cirrhosis and Hepatitis

November 18-19, 2019

19th International Conference on Gastroenterology and Hepatology

Hawthorn Suites By Wyndham Abu Dhabi City Center, Abu Dhabi, UAE
November 18-19, 2019

18th International Conference on Gastroenterology and Digestive Disorders

Hawthorn Suites By Wyndham Abu Dhabi City Center, Abu Dhabi, UAE
March 18-19, 2020

International Conference on Gastroenterology and Liver

Amsterdam, Netherlands
March 18-19, 2020

11th International conference on Liver and Hepatitis

Amsterdam, Netherlands
March 30-31, 2020

7th International Conference on Hepatology

Osaka, Japan
June 24-25, 2020

15th Euro-Global Gastroenterology Conference

Rome, Italy
July 20-21, 2020

20th World Gastroenterologists Summit

Osaka, Japan
September 28-29. 2020

3rd World Liver Congress

Abu Dhabi, UAE
November 16-17, 2020

30th World Congress on Nursing

Brisbane, Australia
December 07-08 , 2020

International Congress on Gastroenterology and Liver Transplant

Auckland, Newzeland

Antiviral Drugs for Cirrhosis and Hepatitis Conference Speakers

Recommended Sessions

Related Journals

Are you interested in